{"id": "article-21268_0", "title": "Epstein-Barr Virus -- Continuing Education Activity", "content": "Epstein Barr virus (EBV) is a herpesvirus in which over 90% of the population worldwide has been infected. EBV infection can range from asymptomatic to infectious mononucleosis. Complications are rare, but important to recognize. This activity reviews the evaluation and management of the Epstein Barr virus and explains the role of the interprofessional team in managing patients with this condition.", "contents": "Epstein-Barr Virus -- Continuing Education Activity. Epstein Barr virus (EBV) is a herpesvirus in which over 90% of the population worldwide has been infected. EBV infection can range from asymptomatic to infectious mononucleosis. Complications are rare, but important to recognize. This activity reviews the evaluation and management of the Epstein Barr virus and explains the role of the interprofessional team in managing patients with this condition."}
{"id": "article-21268_1", "title": "Epstein-Barr Virus -- Continuing Education Activity", "content": "Objectives: Identify the etiology and epidemiology of Epstein Barr virus. Review the physical exam findings and lab results of patients with Epstein Barr virus. Outline the treatment options and possible complications of Epstein Barr virus. Describe the importance of collaboration and communication amongst the interprofessional team to enhance care coordination for patients affected by Epstein Barr virus. Access free multiple choice questions on this topic.", "contents": "Epstein-Barr Virus -- Continuing Education Activity. Objectives: Identify the etiology and epidemiology of Epstein Barr virus. Review the physical exam findings and lab results of patients with Epstein Barr virus. Outline the treatment options and possible complications of Epstein Barr virus. Describe the importance of collaboration and communication amongst the interprofessional team to enhance care coordination for patients affected by Epstein Barr virus. Access free multiple choice questions on this topic."}
{"id": "article-21268_2", "title": "Epstein-Barr Virus -- Introduction", "content": "Epstein Barr virus (EBV) is a double-stranded DNA virus that infects B lymphocyte cells. It is in the herpesvirus family and was discovered in 1964. [1] [2] It can cause a variety of diseases and is spread mainly from saliva containing virus-infected epithelial cells. [1] [3] Close to 95% of adults throughout the world have been infected with EBV. [2] It is a causative agent of infectious mononucleosis. Treatment is generally supportive care. [1]", "contents": "Epstein-Barr Virus -- Introduction. Epstein Barr virus (EBV) is a double-stranded DNA virus that infects B lymphocyte cells. It is in the herpesvirus family and was discovered in 1964. [1] [2] It can cause a variety of diseases and is spread mainly from saliva containing virus-infected epithelial cells. [1] [3] Close to 95% of adults throughout the world have been infected with EBV. [2] It is a causative agent of infectious mononucleosis. Treatment is generally supportive care. [1]"}
{"id": "article-21268_3", "title": "Epstein-Barr Virus -- Etiology", "content": "Epstein Barr virus is a herpesvirus with double-stranded DNA enclosed by proteins. The envelope of the virus has glycoproteins, which are important for attachment and entry into the host cells (B cells and epithelial cells). EBV targets B cells by utilizing their molecular machinery to replicate the viral genome. The virus causes B cells to differentiate into memory B cells, which then can move into the circulatory system, or become latent until a trigger causes reactivation. [1]", "contents": "Epstein-Barr Virus -- Etiology. Epstein Barr virus is a herpesvirus with double-stranded DNA enclosed by proteins. The envelope of the virus has glycoproteins, which are important for attachment and entry into the host cells (B cells and epithelial cells). EBV targets B cells by utilizing their molecular machinery to replicate the viral genome. The virus causes B cells to differentiate into memory B cells, which then can move into the circulatory system, or become latent until a trigger causes reactivation. [1]"}
{"id": "article-21268_4", "title": "Epstein-Barr Virus -- Etiology", "content": "The transmission of the Epstein Barr virus occurs in several ways, such as deep kissing or food-sharing. Increased levels of viral DNA are found in salivary secretions after the initial infection. Children can be infected after eating food that has already been chewed by an EBV infected individual. [3] The transmission has occurred through stem cell and organ transplantation, as well as blood transfusion. [1] [3]", "contents": "Epstein-Barr Virus -- Etiology. The transmission of the Epstein Barr virus occurs in several ways, such as deep kissing or food-sharing. Increased levels of viral DNA are found in salivary secretions after the initial infection. Children can be infected after eating food that has already been chewed by an EBV infected individual. [3] The transmission has occurred through stem cell and organ transplantation, as well as blood transfusion. [1] [3]"}
{"id": "article-21268_5", "title": "Epstein-Barr Virus -- Epidemiology", "content": "Nearly 95% of the world\u2019s population of adults have been infected with the Epstein Barr virus. [2] In the United States, children and adolescents between the ages of 6\u00a0to 19 years had an EBV prevalence of 66.5%. Children between 6-8 years of age had a prevalence of approximately 54%, while adolescents 18-19 years old had a prevalence of 82.9%. More females than males were infected, but the difference was minimal. Children and adolescents who identified as Mexican-American had a higher prevalence of Epstein Barr virus than non-Hispanic Blacks and Whites. There was a higher prevalence of Epstein Barr virus infection in children and adolescents who had larger households, lower household incomes, lower parental education, and who were born outside the U.S. [4]", "contents": "Epstein-Barr Virus -- Epidemiology. Nearly 95% of the world\u2019s population of adults have been infected with the Epstein Barr virus. [2] In the United States, children and adolescents between the ages of 6\u00a0to 19 years had an EBV prevalence of 66.5%. Children between 6-8 years of age had a prevalence of approximately 54%, while adolescents 18-19 years old had a prevalence of 82.9%. More females than males were infected, but the difference was minimal. Children and adolescents who identified as Mexican-American had a higher prevalence of Epstein Barr virus than non-Hispanic Blacks and Whites. There was a higher prevalence of Epstein Barr virus infection in children and adolescents who had larger households, lower household incomes, lower parental education, and who were born outside the U.S. [4]"}
{"id": "article-21268_6", "title": "Epstein-Barr Virus -- Epidemiology", "content": "Worldwide prevalence rates of Epstein Barr virus vary. In England, the Epstein Barr virus prevalence rate for children ages 11 to 24 was 74.6%. Younger patients 11\u00a0to 14 years old had a lower prevalence rate of Epstein Barr virus when compared to older children. Young adults 22\u00a0to 24-year olds had 93% seropositivity. [5] In a study population from Tehran, Iran, the seroprevalence of Epstein Barr virus IgG antibody was 81.4%. Almost 95% of the subjects over 40 years old were seropositive. The prevalence of seropositive subjects increased as age increased, except for in the infant population. Infants had elevated levels of Epstein Barr virus IgG antibodies that decreased as they aged, likely due to loss of maternal antibodies over time. [6] In China, a study showed a prevalence rate of greater than 50% before 3 years of age, and over 90% by ages 8\u00a0to 9 years old. [7]", "contents": "Epstein-Barr Virus -- Epidemiology. Worldwide prevalence rates of Epstein Barr virus vary. In England, the Epstein Barr virus prevalence rate for children ages 11 to 24 was 74.6%. Younger patients 11\u00a0to 14 years old had a lower prevalence rate of Epstein Barr virus when compared to older children. Young adults 22\u00a0to 24-year olds had 93% seropositivity. [5] In a study population from Tehran, Iran, the seroprevalence of Epstein Barr virus IgG antibody was 81.4%. Almost 95% of the subjects over 40 years old were seropositive. The prevalence of seropositive subjects increased as age increased, except for in the infant population. Infants had elevated levels of Epstein Barr virus IgG antibodies that decreased as they aged, likely due to loss of maternal antibodies over time. [6] In China, a study showed a prevalence rate of greater than 50% before 3 years of age, and over 90% by ages 8\u00a0to 9 years old. [7]"}
{"id": "article-21268_7", "title": "Epstein-Barr Virus -- Epidemiology", "content": "One study found that the infection rates tend to increase between June and August, most likely due to increased human interaction during the summer months. [8]", "contents": "Epstein-Barr Virus -- Epidemiology. One study found that the infection rates tend to increase between June and August, most likely due to increased human interaction during the summer months. [8]"}
{"id": "article-21268_8", "title": "Epstein-Barr Virus -- History and Physical", "content": "Determining if a patient has Epstein Barr virus requires a thorough history and physical. Infection with Epstein Barr virus can cause a variety of symptoms, ranging from asymptomatic to a spectrum of illnesses. In children, infection with Epstein Barr virus can often be asymptomatic or present with vague symptoms. [2] Patients infected with Epstein Barr virus can have systemic manifestations including splenomegaly, lymphadenopathy, headache, malaise, fever, and sore throat. [8] Patients may show symptoms for several months, with fatigue as the most common lingering complaint. In a study done by Rea et al., physical exam findings such as cervical lymphadenopathy and pharyngitis, were seen at six months after the initial infection in about one-quarter of the study group (n=140). Lab abnormalities such as lymphocytosis, with a presence of atypical lymphocytes, are most common. Liver function tests can also be abnormally elevated. In some patients, there was even a decline in functional and emotional status while they were sick that improved throughout the study period. [9]", "contents": "Epstein-Barr Virus -- History and Physical. Determining if a patient has Epstein Barr virus requires a thorough history and physical. Infection with Epstein Barr virus can cause a variety of symptoms, ranging from asymptomatic to a spectrum of illnesses. In children, infection with Epstein Barr virus can often be asymptomatic or present with vague symptoms. [2] Patients infected with Epstein Barr virus can have systemic manifestations including splenomegaly, lymphadenopathy, headache, malaise, fever, and sore throat. [8] Patients may show symptoms for several months, with fatigue as the most common lingering complaint. In a study done by Rea et al., physical exam findings such as cervical lymphadenopathy and pharyngitis, were seen at six months after the initial infection in about one-quarter of the study group (n=140). Lab abnormalities such as lymphocytosis, with a presence of atypical lymphocytes, are most common. Liver function tests can also be abnormally elevated. In some patients, there was even a decline in functional and emotional status while they were sick that improved throughout the study period. [9]"}
{"id": "article-21268_9", "title": "Epstein-Barr Virus -- Evaluation", "content": "Determining if a patient has an infection due to Epstein Barr virus is usually most effective through serological testing. Atypical appearing lymphocytosis is most commonly present on peripheral smear. [1] Heterophile antibody tests identify IgM antibodies against EBV. Heterophile antibody testing is a good initial test since it is inexpensive, fast, and has a sensitivity of 63-84% and specificity of 84\u00a0to 100%. [2] [10] The disadvantages of the heterophile antibody test include the possibility of a negative result in children, since they may not produce heterophile antibodies to EBV. Unfortunately, other disease processes can induce heterophile antibodies, or they may be present for over a year, causing a positive result unrelated to an acute EBV infection. [1] [3] Viral capsid antigen (VCA) IgM and IgG can be used to confirm the diagnosis. Elevated levels of VCA IgM antibodies detect an acute infection, while increased VCA IgG antibody levels indicate prior or chronic infection. [1] Patients with EBV who were followed for 6 months showed VCA-IgM antibodies that subsided after a month and VCA-IgG that decreased over time. [9]", "contents": "Epstein-Barr Virus -- Evaluation. Determining if a patient has an infection due to Epstein Barr virus is usually most effective through serological testing. Atypical appearing lymphocytosis is most commonly present on peripheral smear. [1] Heterophile antibody tests identify IgM antibodies against EBV. Heterophile antibody testing is a good initial test since it is inexpensive, fast, and has a sensitivity of 63-84% and specificity of 84\u00a0to 100%. [2] [10] The disadvantages of the heterophile antibody test include the possibility of a negative result in children, since they may not produce heterophile antibodies to EBV. Unfortunately, other disease processes can induce heterophile antibodies, or they may be present for over a year, causing a positive result unrelated to an acute EBV infection. [1] [3] Viral capsid antigen (VCA) IgM and IgG can be used to confirm the diagnosis. Elevated levels of VCA IgM antibodies detect an acute infection, while increased VCA IgG antibody levels indicate prior or chronic infection. [1] Patients with EBV who were followed for 6 months showed VCA-IgM antibodies that subsided after a month and VCA-IgG that decreased over time. [9]"}
{"id": "article-21268_10", "title": "Epstein-Barr Virus -- Treatment / Management", "content": "Epstein Barr virus is treated symptomatically with medications that can reduce fever and pain. [1] Some studies using antiviral medications for EBV treatment did show a decrease in the amount of virus shed in the oral cavity, but there was no improvement in overall symptoms. [2] Corticosteroids are not therapeutic, but they can be beneficial in patients who develop airway compromise or autoimmune complications caused by EBV infection. [1]", "contents": "Epstein-Barr Virus -- Treatment / Management. Epstein Barr virus is treated symptomatically with medications that can reduce fever and pain. [1] Some studies using antiviral medications for EBV treatment did show a decrease in the amount of virus shed in the oral cavity, but there was no improvement in overall symptoms. [2] Corticosteroids are not therapeutic, but they can be beneficial in patients who develop airway compromise or autoimmune complications caused by EBV infection. [1]"}
{"id": "article-21268_11", "title": "Epstein-Barr Virus -- Differential Diagnosis", "content": "Several other diseases need to be considered as part of the differential diagnosis. Bacterial pharyngitis presents with a sore throat, cervical lymphadenopathy, pharyngeal swelling, and tonsillar exudates. Viral pharyngitis usually includes fatigue, fever, rhinorrhea, or conjunctivitis. [11] Cytomegalovirus (CMV) is another virus in the Herpesviridae family that presents similarly to EBV with a sore throat, fevers, chills, elevated liver function tests, and fatigue. Splenomegaly and lymphadenopathy are less common CMV symptoms. [12] Acute HIV infection is also on the differential. These patients present with fevers, muscle and joint pain, fatigue, headaches, and sometimes with lymphadenopathy and pharyngitis. [13]", "contents": "Epstein-Barr Virus -- Differential Diagnosis. Several other diseases need to be considered as part of the differential diagnosis. Bacterial pharyngitis presents with a sore throat, cervical lymphadenopathy, pharyngeal swelling, and tonsillar exudates. Viral pharyngitis usually includes fatigue, fever, rhinorrhea, or conjunctivitis. [11] Cytomegalovirus (CMV) is another virus in the Herpesviridae family that presents similarly to EBV with a sore throat, fevers, chills, elevated liver function tests, and fatigue. Splenomegaly and lymphadenopathy are less common CMV symptoms. [12] Acute HIV infection is also on the differential. These patients present with fevers, muscle and joint pain, fatigue, headaches, and sometimes with lymphadenopathy and pharyngitis. [13]"}
{"id": "article-21268_12", "title": "Epstein-Barr Virus -- Prognosis", "content": "Infectious mononucleosis caused by Epstein Barr virus is a self-limiting disease with a relatively good prognosis, as most patients will improve over time. [9] However, there are complications from having EBV infection, which vary in frequency. [1]", "contents": "Epstein-Barr Virus -- Prognosis. Infectious mononucleosis caused by Epstein Barr virus is a self-limiting disease with a relatively good prognosis, as most patients will improve over time. [9] However, there are complications from having EBV infection, which vary in frequency. [1]"}
{"id": "article-21268_13", "title": "Epstein-Barr Virus -- Complications", "content": "Epstein Barr virus has several associated complications. One dangerous complication is splenic rupture due to infectious mononucleosis. In one case study, splenic rupture occurred 6 days after symptoms of infection. It can be treated conservatively or surgically. Pain control and close monitoring are appropriate conservative management strategies reserved for hemodynamically stable patients. Another non-surgical management option is splenic artery embolization. The surgical option is splenectomy which requires post-operative immunizations, antibiotics, and close follow-up. [14]", "contents": "Epstein-Barr Virus -- Complications. Epstein Barr virus has several associated complications. One dangerous complication is splenic rupture due to infectious mononucleosis. In one case study, splenic rupture occurred 6 days after symptoms of infection. It can be treated conservatively or surgically. Pain control and close monitoring are appropriate conservative management strategies reserved for hemodynamically stable patients. Another non-surgical management option is splenic artery embolization. The surgical option is splenectomy which requires post-operative immunizations, antibiotics, and close follow-up. [14]"}
{"id": "article-21268_14", "title": "Epstein-Barr Virus -- Complications", "content": "Another complication of infectious mononucleosis from EBV is airway obstruction from tonsillar edema of the pharyngeal tissues. Treatment of airway obstruction includes steroids, tracheotomy, or intubation. Airway obstruction is a rare (1-3.5% of cases) but an important complication of infectious mononucleosis that occurs mostly in children. [2] [15] [16]", "contents": "Epstein-Barr Virus -- Complications. Another complication of infectious mononucleosis from EBV is airway obstruction from tonsillar edema of the pharyngeal tissues. Treatment of airway obstruction includes steroids, tracheotomy, or intubation. Airway obstruction is a rare (1-3.5% of cases) but an important complication of infectious mononucleosis that occurs mostly in children. [2] [15] [16]"}
{"id": "article-21268_15", "title": "Epstein-Barr Virus -- Complications", "content": "Acute acalculous cholecystitis is a complication that can be treated conservatively with pain medication and antiemetics. [17] [18] In some cases, patients elected to have laparoscopic cholecystectomy due to unbearable abdominal pain. [18]", "contents": "Epstein-Barr Virus -- Complications. Acute acalculous cholecystitis is a complication that can be treated conservatively with pain medication and antiemetics. [17] [18] In some cases, patients elected to have laparoscopic cholecystectomy due to unbearable abdominal pain. [18]"}
{"id": "article-21268_16", "title": "Epstein-Barr Virus -- Complications", "content": "There are many other complications from Epstein Barr virus infection that can occur, such as myocarditis, encephalitis, hemophagocytic lymphohistiocytosis, pancreatitis, and autoimmune hemolytic anemia. [19] [20] [21] [22] EBV has also been implicated in causing lymphomas and nasopharyngeal cancers. [1]", "contents": "Epstein-Barr Virus -- Complications. There are many other complications from Epstein Barr virus infection that can occur, such as myocarditis, encephalitis, hemophagocytic lymphohistiocytosis, pancreatitis, and autoimmune hemolytic anemia. [19] [20] [21] [22] EBV has also been implicated in causing lymphomas and nasopharyngeal cancers. [1]"}
{"id": "article-21268_17", "title": "Epstein-Barr Virus -- Deterrence and Patient Education", "content": "Infected patients should avoid sharing utensils, drinks, and kissing others since EBV is transmitted through saliva. [1] Patients in sports should be cleared by a\u00a0clinician before resuming activities. A minimum of three weeks and full resolution of splenomegaly is standard to decrease the risk of splenic rupture. [2]", "contents": "Epstein-Barr Virus -- Deterrence and Patient Education. Infected patients should avoid sharing utensils, drinks, and kissing others since EBV is transmitted through saliva. [1] Patients in sports should be cleared by a\u00a0clinician before resuming activities. A minimum of three weeks and full resolution of splenomegaly is standard to decrease the risk of splenic rupture. [2]"}
{"id": "article-21268_18", "title": "Epstein-Barr Virus -- Enhancing Healthcare Team Outcomes", "content": "Patients with EBV infection should be under the care of an interprofessional team including primary clinicians, nurses, and pharmacists to improve outcomes. As shown in a prospective study done by Rea et al., symptoms can last for several months (Level 5). [9] Patients should be instructed on what symptoms to expect and for how long to expect them to last. They should be aware of possible complications and when to seek help. Patients who participate in sports need medical clearance and a minimum of three weeks before returning to activities to reduce the risk of splenic rupture. [2]", "contents": "Epstein-Barr Virus -- Enhancing Healthcare Team Outcomes. Patients with EBV infection should be under the care of an interprofessional team including primary clinicians, nurses, and pharmacists to improve outcomes. As shown in a prospective study done by Rea et al., symptoms can last for several months (Level 5). [9] Patients should be instructed on what symptoms to expect and for how long to expect them to last. They should be aware of possible complications and when to seek help. Patients who participate in sports need medical clearance and a minimum of three weeks before returning to activities to reduce the risk of splenic rupture. [2]"}
{"id": "article-21268_19", "title": "Epstein-Barr Virus -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Epstein-Barr Virus -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}